Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
ENZON PHARMACEUTICALS, INC.
ENZN
Other
Auditor Appointment Ratification
Auditor Change
Form 8K Filing Disclosure
Core
Management Exodus
Other
Director Continuity Stated
Other
Nyse Listing Disclosure
Board Committee Composition Disclosure
Form 8K Filing Disclosure
Reverse Stock Split Effected
Other
Reverse Stock Split Effected
Exchange Offer Expiration Disclosed
Nyse Listing Disclosure
Other
Exchange Offer Expiration Disclosed
Other
Exchange Offer Expiration Disclosed
Other
Exchange Offer Expiration Disclosed
Other
Deferred Tax Asset Valuation Disclosure
Nyse Listing Disclosure
Reverse Stock Split Effected
Market Volatility Risk Disclosure
Quarterly Dividend Declared
Net Loss Reported
Valuation Allowance Deferred Tax Disclosure
Ipo Or Capital Raising Completion
Fair Value Hierarchy Reconciliation Disclosed
Board Esg Risk Oversight Disclosed
Nol Tax Credit Carryforward
Nol Carryforward Expiration Disclosure
Patent Family Portfolio Disclosure
Shareholder Dilution Warning
Shares Outstanding Disclosure
Other
Exchange Offer Expiration Disclosed
Form S3 Shelf Registration Disclosure
Other
Form S3 Shelf Registration Disclosure
No signals above threshold for this filing.
No signals above threshold for this filing.
Other
Deferred Tax Asset Valuation Disclosure
Nol Carryforward Expiration Disclosure
Nol Tax Credit Carryforward
Fair Value Hierarchy Reconciliation Disclosed
Quarterly Tax Provision Benefit Disclosure
Personnel Cost Decrease Disclosure
Administrative Efficiency
Liquidity Position Snapshot Disclosed
Acquisition And Management Fees Disclosed
Quarterly Dividend Declared
Form S3 Shelf Registration Disclosure
Burn Rate Controlled
Merger Proxy Statement Disclosure
Interest Income Year Over Year Comparison
Net Loss Reported
Other
Incorporation Or Reincorporation Disclosure
Reverse Stock Split Effected
Liquidity Position Snapshot Disclosed
Amendment Modification Waiver Clause